APA (7th ed.) Citation

Hakozaki, T., Richard, C., Elkrief, A., Hosomi, Y., Benlaïfaoui, M., Mimpen, I., . . . Okuma, Y. (2020). The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer. Cancer immunology research, 8(10), 1243. https://doi.org/10.1158/2326-6066.CIR-20-0196

Chicago Style (17th ed.) Citation

Hakozaki, Taiki, et al. "The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer." Cancer Immunology Research 8, no. 10 (2020): 1243. https://doi.org/10.1158/2326-6066.CIR-20-0196.

MLA (9th ed.) Citation

Hakozaki, Taiki, et al. "The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer." Cancer Immunology Research, vol. 8, no. 10, 2020, p. 1243, https://doi.org/10.1158/2326-6066.CIR-20-0196.